FindTrial
Sign In

To study the efficiency of a plastic device which helps in separating the blood components

Cartridge Design Study on Neonates - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/06/005883
Enrollment
25
Registered
2015-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Neonatal Jaundice

Interventions

Intervention1: Cartridge: To separate the plasma from the blood cells. Intervention2: Cartridge: To separate the blood cells from the plasma Control Intervention1: NA: NA Control Intervention2: Not Ap

Sponsors

Philips Electronics India Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Term and preterm neonates above birth weight of 2 kg who are generally healthy and do not have obvious morbidity.

Exclusion criteria

Exclusion criteria: (i) Very sick neonates as understood to need ventilatory support, intensive monitoring and care. (ii) Babies with bilirubin levels close to exchange transfusion who will anyway need intense monitoring of bilirubin levels. (iii) Any other reason which may warrant intense monitoring of bilirubin levels

Design outcomes

Primary

MeasureTime frame
To determine the success of new cartridge design on neonates, which is judged by a scoring systemTimepoint: Completion of the Scores—

Secondary

MeasureTime frame
(i) To determine efficacy of plasma separation from neonate blood in new cartridge. (ii) To determine the flow of plasma in the portTimepoint: 2 minutes after the application of the blood.—

Countries

India

Contacts

Public ContactAnil Raiker

Philips Research India - Bangalore

Anil.Raikar@philips.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026